Nanotechnology Now

Our NanoNews Digest Sponsors
Heifer International



Home > Press > Altogen Biosystems Launches Custom Biotechnology Research Services: Generation of Stable Cell Lines and RNAi Cell Transfection Services

Abstract:
Altogen Biosystems
(http://www.altogen.com) announced launch of new contract research
services. Located in Las Vegas, NV, Altogen Custom Services focus on
providing specialized biotechnology and pharmaceutical services, including
RNA Interference (RNAi) services, generation of stably-expressing cell
lines, assay development, screening and transfection services. In
particular, the company will draw upon their unique experience with over
hundred cancer cell lines and expertise in polymer and nanoparticle-based
gene delivery technologies.

Altogen Biosystems Launches Custom Biotechnology Research Services: Generation of Stable Cell Lines and RNAi Cell Transfection Services

LAS VEGAS, NV | Posted on March 12th, 2008

Generation of stably-expressing cancer cell lines and primary cells can
be very expensive and time-consuming. Utilizing this method, investigators
are able to develop cells that permanently express specific genes through
their incorporation in the cellular genome. Altogen Custom Services offers
generation of stable cell lines by transforming the cell line of choice to
stably express vector or gene of interest. Optional cloning and shRNA
expression services are available. The service turnaround time is typically
3-4 weeks.

Altogen laboratory research services
(www.altogen.com/support.htm) include:

-- Transfection services (transient and stable)
-- Assay development and library screening
-- Cloning and plasmid vector construction
-- Generation of stable cell lines
-- RNAi experiments (siRNA design, synthesis, validation)
-- Gene targeting (mRNA knockdown, shRNA overexpression)
-- Custom services

####

About Altogen Biosystems
Altogen Biosystems is a life sciences company dedicated to the
development, marketing and manufacture of In Vivo and In Vitro transfection
reagents for intracellular and tissue-targeted delivery of biomolecules.
Altogen Custom Services is a laboratory contract research organization. It
provides specialized contract research to pharmaceutical, biotechnology,
and other life science organizations worldwide.

For more information, please click here

Contacts:
Altogen Biosystems
848 Rainbow Blvd #823
Las Vegas, NV 89107 USA
Tel/Fax: 1-702-989-0841

Customer Support:
1-800-658-7009
Fax: (702) 989-0841

Copyright © PR Newswire Association LLC.

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024

Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024

Nanotechnology: Flexible biosensors with modular design November 8th, 2024

Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024

Nanomedicine

Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024

NYU Abu Dhabi researchers develop novel covalent organic frameworks for precise cancer treatment delivery: NYU Abu Dhabi researchers develop novel covalent organic frameworks for precise cancer treatment delivery September 13th, 2024

Unveiling the power of hot carriers in plasmonic nanostructures August 16th, 2024

Nanobody inhibits metastasis of breast tumor cells to lung in mice: “In the present study we describe the development of an inhibitory nanobody directed against an extracellular epitope present in the native V-ATPase c subunit.” August 16th, 2024

Announcements

Nanotechnology: Flexible biosensors with modular design November 8th, 2024

Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024

Turning up the signal November 8th, 2024

Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024

Nanobiotechnology

Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024

NYU Abu Dhabi researchers develop novel covalent organic frameworks for precise cancer treatment delivery: NYU Abu Dhabi researchers develop novel covalent organic frameworks for precise cancer treatment delivery September 13th, 2024

Nanobody inhibits metastasis of breast tumor cells to lung in mice: “In the present study we describe the development of an inhibitory nanobody directed against an extracellular epitope present in the native V-ATPase c subunit.” August 16th, 2024

The mechanism of a novel circular RNA circZFR that promotes colorectal cancer progression July 5th, 2024

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project